Craigakess you have faith if you want to admit it or not that’s your business. You wouldn’t be here if you didn’t see the up side of this investment. As for realist? Naw... a realist would see the multiple paths this drug has and would acknowledge just how special things could be. As for “also ran” I hardly think you can label Leronlimab a defeated drug. It’s more of a fledgling drug just getting its wings. That’s the realist look at Leronlimab.
It’s going to be a wild ride with so much damn potential you would not sell a share to short your investment before the pending approval happens. Like you. I am green and not worried and have an average of .34/share. Worried... nope. Have time... yep... as we all do. But how much more time will we need to get our Covid approval?
To dismiss Covid is silly. We have 70-75% of all future hospital treated patients in Long Haulers. Nobody else trialing yet for that LH group. We are in a class by ourself on Severe/Critical. Once you get past the viral stage it’s all Leronlimab and people will know this. Why? Because once we get any form of EUA and a few papers written in journals come to light. Everyone will know the MAB that is the one you want. The one that stops the cytokine storm and stops the viral load. Then does this little immune system reset. This is what separates Leronlimab from all others. The immune response gets reversed and it turns negative cells to positive cells and no other drug trialed does this. Dare I say... we are in a class all by ourself. Do we need to compete with other drugs? Ok... a little competition but REALITY is they are not really competition. They are wannabes like Dr. Patterson said in his Tedx Talk. They are piece meal and nothing like the 3 functions of Leronlimab. Where one drug it would seem is designed for covid. There will be drugs and there will be winners and losers. I would not bet on Leronlimab as a loser. Or a “also ran”. Maybe you should watch Dr. Patterson’s TEDx Talk again. It’s pinned at the top of this page. He thinks we are in a different class all together. I have nothing but respect for Dr. Patterson. He made me a believer. He is a well respected man on this board and as professional as they come as a teacher. Watch his video and learn. It’s good remedial information in case you have forgotten any of the important points he makes.
It’s going to be a wild ride with so much damn potential you would not sell a share to short your investment before the pending approval happens. Like you. I am green and not worried and have an average of .34/share. Worried... nope. Have time... yep... as we all do. But how much more time will we need to get our Covid approval?
To dismiss Covid is silly. We have 70-75% of all future hospital treated patients in Long Haulers. Nobody else trialing yet for that LH group. We are in a class by ourself on Severe/Critical. Once you get past the viral stage it’s all Leronlimab and people will know this. Why? Because once we get any form of EUA and a few papers written in journals come to light. Everyone will know the MAB that is the one you want. The one that stops the cytokine storm and stops the viral load. Then does this little immune system reset. This is what separates Leronlimab from all others. The immune response gets reversed and it turns negative cells to positive cells and no other drug trialed does this. Dare I say... we are in a class all by ourself. Do we need to compete with other drugs? Ok... a little competition but REALITY is they are not really competition. They are wannabes like Dr. Patterson said in his Tedx Talk. They are piece meal and nothing like the 3 functions of Leronlimab. Where one drug it would seem is designed for covid. There will be drugs and there will be winners and losers. I would not bet on Leronlimab as a loser. Or a “also ran”. Maybe you should watch Dr. Patterson’s TEDx Talk again. It’s pinned at the top of this page. He thinks we are in a different class all together. I have nothing but respect for Dr. Patterson. He made me a believer. He is a well respected man on this board and as professional as they come as a teacher. Watch his video and learn. It’s good remedial information in case you have forgotten any of the important points he makes.
11
2
